Revive Therapeutics Ltd. (RVV.CN)
CAD 0.01
(-50.0%)
CAD 0.01
(-50.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 3.28 Million CAD | -40.49% |
| 2022 | 5.52 Million CAD | -69.04% |
| 2021 | 17.83 Million CAD | -4.08% |
| 2020 | 18.59 Million CAD | 404.73% |
| 2019 | 3.68 Million CAD | 179.07% |
| 2018 | 1.31 Million CAD | -28.44% |
| 2017 | 1.84 Million CAD | 10.2% |
| 2016 | 1.67 Million CAD | -37.95% |
| 2015 | 2.69 Million CAD | 33.82% |
| 2014 | 2.01 Million CAD | 121.95% |
| 2013 | 908.28 Thousand CAD | 369.66% |
| 2012 | 193.39 Thousand CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q3 | 1.85 Million CAD | 136.6% |
| 2023 Q4 | 233.24 Thousand CAD | -87.43% |
| 2023 Q1 | 413.52 Thousand CAD | 16.52% |
| 2023 Q2 | 784.25 Thousand CAD | 89.65% |
| 2022 Q2 | 1.53 Million CAD | -8.48% |
| 2022 Q1 | 1.67 Million CAD | -40.17% |
| 2022 FY | 5.52 Million CAD | -69.04% |
| 2022 Q4 | 354.89 Thousand CAD | -81.89% |
| 2022 Q3 | 1.95 Million CAD | 27.89% |
| 2021 FY | 17.83 Million CAD | -4.08% |
| 2021 Q2 | 4.11 Million CAD | -15.85% |
| 2021 Q3 | 6.02 Million CAD | 46.52% |
| 2021 Q4 | 2.79 Million CAD | -53.59% |
| 2021 Q1 | 4.89 Million CAD | -31.6% |
| 2020 Q2 | 2.64 Million CAD | -34.46% |
| 2020 Q3 | 4.26 Million CAD | 61.42% |
| 2020 Q4 | 7.15 Million CAD | 67.59% |
| 2020 FY | 18.59 Million CAD | 404.73% |
| 2020 Q1 | 4.03 Million CAD | 188.98% |
| 2019 Q3 | 1.65 Million CAD | 389.5% |
| 2019 Q2 | 337.13 Thousand CAD | 12.14% |
| 2019 Q4 | 1.39 Million CAD | -15.44% |
| 2019 Q1 | 300.63 Thousand CAD | -31.32% |
| 2019 FY | 3.68 Million CAD | 179.07% |
| 2018 FY | 1.31 Million CAD | -28.44% |
| 2018 Q4 | 437.76 Thousand CAD | 73.78% |
| 2018 Q3 | 251.9 Thousand CAD | -22.11% |
| 2018 Q2 | 323.42 Thousand CAD | 5.39% |
| 2018 Q1 | 306.88 Thousand CAD | -45.91% |
| 2017 Q3 | 400.96 Thousand CAD | -7.74% |
| 2017 Q4 | 567.33 Thousand CAD | 41.49% |
| 2017 FY | 1.84 Million CAD | 10.2% |
| 2017 Q2 | 434.61 Thousand CAD | -1.68% |
| 2017 Q1 | 442.06 Thousand CAD | -25.58% |
| 2016 Q1 | 356.58 Thousand CAD | -24.9% |
| 2016 FY | 1.67 Million CAD | -37.95% |
| 2016 Q4 | 594.01 Thousand CAD | 31.21% |
| 2016 Q3 | 452.72 Thousand CAD | 67.41% |
| 2016 Q2 | 270.42 Thousand CAD | -24.16% |
| 2015 Q3 | 496.65 Thousand CAD | -38.82% |
| 2015 Q2 | 811.82 Thousand CAD | -11.06% |
| 2015 FY | 2.69 Million CAD | 33.82% |
| 2015 Q1 | 912.79 Thousand CAD | 53.11% |
| 2015 Q4 | 474.78 Thousand CAD | -4.4% |
| 2014 Q4 | 596.16 Thousand CAD | 3.57% |
| 2014 Q3 | 575.64 Thousand CAD | 24.95% |
| 2014 Q2 | 460.7 Thousand CAD | 20.28% |
| 2014 Q1 | 383.02 Thousand CAD | -52.69% |
| 2014 FY | 2.01 Million CAD | 121.95% |
| 2013 Q2 | 211.49 Thousand CAD | 154.41% |
| 2013 Q3 | 278.87 Thousand CAD | 31.86% |
| 2013 Q4 | 809.61 Thousand CAD | 190.32% |
| 2013 Q1 | 83.13 Thousand CAD | 2510.11% |
| 2013 FY | 908.28 Thousand CAD | 369.66% |
| 2012 Q2 | 62.13 CAD | 742.77% |
| 2012 Q1 | 7.37 CAD | 0.0% |
| 2012 FY | 193.39 Thousand CAD | 0.0% |
| 2012 Q3 | 29.16 Thousand CAD | 46841.04% |
| 2012 Q4 | 3185.00 CAD | -89.08% |
| 2011 Q4 | - CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Aion Therapeutic Inc. | 163.11 Thousand CAD | -1914.331% |
| Ayurcann Holdings Corp. | 11.71 Million CAD | 71.956% |
| Blueberries Medical Corp. | 84.22 Thousand CAD | -3801.117% |
| The BC Bud Corporation | 1.28 Million CAD | -156.1% |
| BioNxt Solutions Inc. | 6.73 Million CAD | 51.247% |
| CordovaCann Corp. | 3.86 Million CAD | 14.913% |
| Christina Lake Cannabis Corp. | 4.28 Million CAD | 23.288% |
| Captor Capital Corp. | 16.28 Million CAD | 79.82% |
| City View Green Holdings Inc. | 705.7 Thousand CAD | -365.591% |
| 1CM Inc. | 7.3 Million CAD | 55.039% |
| Global Hemp Group Inc. | 551.7 Thousand CAD | -495.553% |
| Greenway Greenhouse Cannabis Corporation | 4.8 Million CAD | 31.656% |
| IM Cannabis Corp. | 22.63 Million CAD | 85.486% |
| Lobe Sciences Ltd. | 4.13 Million CAD | 20.485% |
| Maple Leaf Green World Inc. | 392.21 Thousand CAD | -737.731% |
| Mountain Valley MD Holdings Inc. | 60 Thousand CAD | -5376.193% |
| Nextleaf Solutions Ltd. | 1.76 Million CAD | -85.843% |
| Ovation Science Inc. | 54.1 Thousand CAD | -5973.412% |
| Pharmadrug Inc. | 1.33 Million CAD | -146.119% |
| Captiva Verde Wellness Corp. | 1.3 Million CAD | -151.701% |
| RAMM Pharma Corp. | 7.48 Million CAD | 56.076% |
| RIV Capital Inc. | 21.1 Million CAD | 84.43% |
| Red White & Bloom Brands Inc. | 37.75 Million CAD | 91.298% |
| SLANG Worldwide Inc. | 24.6 Million CAD | 86.647% |
| 1933 Industries Inc. | 5.12 Million CAD | 35.892% |
| Red Light Holland Corp. | 2.02 Million CAD | -62.622% |
| Top Strike Resources Corp. | 3.63 Million CAD | 9.528% |
| Xebra Brands Ltd. | -308.42 Thousand CAD | 1165.331% |
| Adastra Holdings Ltd. | 9.36 Million CAD | 64.898% |